Disclaimers & Regulatory Disclosures
1. No medical advice
The content of this website, including the Learning Hub, stories, podcasts and videos, is general information about Clear Health Pass and its products and programs. It is not medical advice, does not create a physician–patient relationship, and is not a substitute for the judgment of a licensed healthcare professional. Rampart™ DL Matrix is applied by licensed clinicians. Patients should direct questions about treatment to their own provider.
2. Product regulatory status
Rampart™ DL Matrix is a human cell, tissue, and cellular and tissue-based product regulated by the U.S. Food and Drug Administration under Section 361 of the Public Health Service Act and 21 CFR Part 1271. It is not FDA-approved or FDA-cleared, and FDA has not evaluated the statements on this website. Products described as in development, benchtop or research are not available for sale, and their described functions are design goals, not demonstrated performance.
3. Coverage and payment
Coverage and payment for any product are determined by Medicare Administrative Contractors and other payers under their own policies, including applicable Local Coverage Determinations, and are subject to change. Nothing on this website guarantees coverage, payment or any particular reimbursement. Healthcare providers are responsible for the accuracy of their own claims and documentation. Clear Health Pass does not practice medicine and does not determine medical necessity.
4. Planned peptide and healthspan programs
Clear Health Pass’s peptide and healthspan pathways are planned programs. No service, product or research enrollment is offered. Research would require an Investigational New Drug application in effect, institutional review board approval and informed consent, none of which has been obtained; services would require state and federal clearances that have not been obtained. No peptide is described on this website as safe or effective for any use, and nothing on this website is an offer of, or a recommendation to obtain or use, any peptide product. Descriptions of research areas are hypotheses, not established uses.
5. Tribal relationship
Clear Health Pass Holdings, LLC is a limited liability company that acts as authorized Tribal Agent and Program Manager for the Tribal Biotechnology & Health Consortium under written delegations. The Consortium is chartered under tribal law and owned by federally recognized tribal economic development corporations organized under Sections 16 and 17 of the Indian Reorganization Act (25 U.S.C. §§ 5123–5124). Clear Health Pass is not a tribe or a tribal entity, does not itself possess sovereign immunity, and acts only within the scope of those delegations. Nothing on this website waives the sovereign immunity of any tribe, tribal corporation or the Consortium, and nothing on this website speaks for any tribal government except as expressly authorized in writing. References to federal agencies, Medicare contractors and their personnel describe events in the public record; no meeting described on this website was a tribal consultation under any agency’s tribal consultation policy, and no agency endorsement is implied.
6. Forward-looking statements
This website contains forward-looking statements, including statements about planned products, research programs, service pathways, facilities, tribal onboarding, regulatory engagement, intellectual property and expected business results. They are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially, including regulatory and reimbursement changes, the outcome of federal rulemaking and any challenge to it, patent prosecution, clinical results, state licensure and market acceptance. Clear Health Pass Holdings, LLC and Clear Health Pass Wound Care LLC are private companies and the safe harbor of the Private Securities Litigation Reform Act does not apply to them. We undertake no obligation to update forward-looking statements.
7. Securities disclosures
Nothing on this website is an offer to sell or a solicitation of an offer to buy any security. The securities currently offered are membership units of Clear Health Pass Wound Care LLC, a subsidiary of Clear Health Pass Holdings, LLC; Clear Health Pass Holdings, LLC is not the issuer. The offering is made only through the private placement memorandum and subscription documents, only in reliance on Rule 506(c) of Regulation D under the Securities Act of 1933, and only to investors whose status as “accredited investors” under Rule 501(a) has been verified by the issuer before any sale. Summaries of offering terms on this website are provided for convenience, are qualified in their entirety by the offering documents, and may be out of date. The securities have not been registered with the U.S. Securities and Exchange Commission or any state securities regulator, and no regulator has reviewed, approved or passed upon the offering or the accuracy of any information on this website. Rule 506 securities are “covered securities” under federal law, but notice filings may be required in the states where investors reside, and the issuer makes the filings it believes are required. An investment in a private company involves a high degree of risk, including the loss of the entire investment; the securities are illiquid, are subject to transfer restrictions and may never have a public market. No return, exit, listing or liquidity is promised. Prospective investors should rely only on the offering documents and consult their own advisors.
8. Intellectual property and trademarks
Rampart™ is a trademark of the Tribal Biotechnology & Health Consortium, the subject of a pending application with the U.S. Patent and Trademark Office, and is used by Clear Health Pass under license. WoundGraft Pro™, WoundGuide™, Clear Health Pass™ and the names of pipeline products are trademarks of Clear Health Pass Holdings, LLC, the subject of pending applications. No trademark referenced on this website is registered; the ™ symbol indicates a claim of rights and not registration. “Patent pending” and “provisional filings” refer to provisional applications filed with the U.S. Patent and Trademark Office; no patents have issued, and the scope of any future patent is not assured. Other names and marks belong to their owners.
9. Third-party content, images and external links
Industry news items are editorial summaries of third-party sources and are not statements of Clear Health Pass’s operational status. Illustrative images on this website are stock or AI-generated and do not depict actual patients, clinicians or events unless stated. Links to external websites are provided for convenience; we are not responsible for their content.
10. Use of artificial intelligence
Clear Health Pass uses artificial-intelligence tools in developing its platform, in producing website content and imagery, and in internal operations. The platform’s measurement, documentation and coverage-check functions support clinicians; they do not diagnose, do not make treatment decisions and do not replace clinical judgment. This website does not provide AI-generated health information to patients.
11. Website terms
This website is provided “as is.” Clear Health Pass makes no warranty as to the completeness or accuracy of its content and may change the content at any time. To the fullest extent permitted by law, Clear Health Pass is not liable for any loss arising from use of or reliance on this website. Website content may not be copied or republished without permission, except that press releases may be quoted with attribution.
12. Contact
Clear Health Pass Holdings, LLC · 3301 North University Drive, Suite 100 #1117, Coral Springs, FL 33065 · contact@clearhealthpass.com
